Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 476739, 5 pages
http://dx.doi.org/10.1155/2012/476739
Review Article

Pathological Scenario with the Mannose-Binding Lectin in Patients with IgA Nephropathy

Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan

Received 24 December 2011; Accepted 26 January 2012

Academic Editor: Misao Matsushita

Copyright © 2012 Isao Ohsawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. V. Donadio and J. P. Grande, “IgA nephropathy,” New England Journal of Medicine, vol. 347, no. 10, pp. 738–748, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Suzuki, K. Kiryluk, J. Novak et al., “The pathophysiology of IgA nephropathy,” Journal of the American Society of Nephrology, vol. 22, no. 10, pp. 1795–1803, 2011. View at Publisher · View at Google Scholar
  3. A. Vangelista, G. M. Frascà, S. Mondini, and V. Bonomini, “Idiopathic IgA mesangial nephropathy: immunohistological features,” Contributions to Nephrology, vol. 40, pp. 167–173, 1984. View at Google Scholar · View at Scopus
  4. M. Haas, “Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases,” American Journal of Kidney Diseases, vol. 29, no. 6, pp. 829–842, 1997. View at Google Scholar · View at Scopus
  5. R. J. Wyatt and B. A. Julian, “Activation of complement in IgA nephropathy,” American Journal of Kidney Diseases, vol. 12, no. 5, pp. 437–442, 1988. View at Google Scholar · View at Scopus
  6. M. M. Dean, R. M. Minchinton, S. Heatley, and D. P. Eisen, “Mannose binding lectin acute phase activity in patients with severe infection,” Journal of Clinical Immunology, vol. 25, no. 4, pp. 346–352, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Onda, H. Ohi, M. Tamano et al., “Hypercomplementemia in adult patients with IgA nephropathy,” Journal of Clinical Laboratory Analysis, vol. 21, no. 2, pp. 77–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Lhotta, R. Würzner, and P. König, “Glomerular deposition of mannose-binding lectin in human glomerulonephritis,” Nephrology Dialysis Transplantation, vol. 14, no. 4, pp. 881–886, 1999. View at Google Scholar · View at Scopus
  9. A. Roos, M. P. Rastaldi, N. Calvaresi et al., “Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease,” Journal of the American Society of Nephrology, vol. 17, no. 6, pp. 1724–1734, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Tomino, M. Endoh, Y. Nomoto, and H. Sakai, “Immunoglobulin A1 and IgA nephropathy,” New England Journal of Medicine, vol. 305, no. 19, pp. 1159–1160, 1981. View at Google Scholar · View at Scopus
  11. Y. Tomino, H. Sakai, and M. Miura, “Detection of polymeric IgA in glomeruli from patients with IgA nephropathy,” Clinical and Experimental Immunology, vol. 49, no. 2, pp. 419–425, 1982. View at Google Scholar · View at Scopus
  12. M. E. Conley, M. D. Cooper, and A. F. Michael, “Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus,” Journal of Clinical Investigation, vol. 66, no. 6, pp. 1432–1436, 1980. View at Google Scholar · View at Scopus
  13. Y. Hiki, H. Odani, M. Takahashi et al., “Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy,” Kidney International, vol. 59, no. 3, pp. 1077–1085, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. A. C. Allen, S. J. Harper, and J. Feehally, “Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy,” Clinical and Experimental Immunology, vol. 100, no. 3, pp. 470–474, 1995. View at Google Scholar · View at Scopus
  15. M. Tomana, K. Matousovic, B. A. Julian, J. Radl, K. Konecny, and J. Mestecky, “Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG,” Kidney International, vol. 52, no. 2, pp. 509–516, 1997. View at Google Scholar · View at Scopus
  16. R. J. Glassock, “The pathogenesis of IgA nephropathy,” Current Opinion in Nephrology and Hypertension, vol. 20, no. 2, pp. 153–160, 2011. View at Publisher · View at Google Scholar
  17. T. Kokubo, Y. Hiki, H. Iwase et al., “Protective role of IgA1 glycans against IgA1 self- aggregation and adhesion to extracellular matrix proteins,” Journal of the American Society of Nephrology, vol. 9, no. 11, pp. 2048–2054, 1998. View at Google Scholar · View at Scopus
  18. A. Roos, L. H. Bouwman, D. J. Van Gijlswijk-Janssen, M. C. Faber-Krol, G. L. Stahl, and M. R. Daha, “Human IgA activates the complement system via the Mannan-Binding lectin pathway,” Journal of Immunology, vol. 167, no. 5, pp. 2861–2868, 2001. View at Google Scholar · View at Scopus
  19. K. Drickamer, “Engineering galactose-binding activity into a C-type mannose-binding protein,” Nature, vol. 360, no. 6400, pp. 183–186, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Coppo and A. Amore, “Aberrant glycosylation in IgA nephropathy (IgAN),” Kidney International, vol. 65, no. 5, pp. 1544–1547, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Royle, A. Roos, D. J. Harvey et al., “Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems,” Journal of Biological Chemistry, vol. 278, no. 22, pp. 20140–20153, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. B. D. Oortwijn, M. P. Rastaldi, A. Roos, D. Mattinzoli, M. R. Daha, and C. Van Kooten, “Demonstration of secretory IgA in kidneys of patients with IgA nephropathy,” Nephrology Dialysis Transplantation, vol. 22, no. 11, pp. 3191–3195, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Garred, F. Larsen, J. Seyfarth, R. Fujita, and H. O. Madsen, “Mannose-binding lectin and its genetic variants,” Genes and Immunity, vol. 7, no. 2, pp. 85–94, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Pirulli, M. Boniotto, L. Vatta et al., “Polymorphisms in the promoter region and at codon 54 of the MBL2 gene are not associated with IgA nephropathy,” Nephrology Dialysis Transplantation, vol. 16, no. 4, pp. 759–764, 2001. View at Google Scholar · View at Scopus
  25. M. Endo, H. Ohi, I. Ohsawa, T. Fujita, M. Matsushita, and T. Fujita, “Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy,” Nephrology Dialysis Transplantation, vol. 13, no. 8, pp. 1984–1990, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Hisano, M. Matsushita, T. Fujita, Y. Endo, and S. Takebayashi, “Mesangial IgA2 deposits and lectin pathway—mediated complement activation in IgA glomerulonephritis,” American Journal of Kidney Diseases, vol. 38, no. 5, pp. 1082–1088, 2001. View at Google Scholar · View at Scopus
  27. N. Sato, I. Ohsawa, S. Nagamachi et al., “Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis,” Lupus, vol. 20, no. 13, pp. 1378–1386, 2011. View at Publisher · View at Google Scholar
  28. M. Espinosa, R. Ortega, J. M. Gómez-Carrasco et al., “Mesangial C4d deposition: a new prognostic factor in IgA nephropathy,” Nephrology Dialysis Transplantation, vol. 24, no. 3, pp. 886–891, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Hisano, M. Matsushita, T. Fujita, M. Takeshita, and H. Iwasaki, “Activation of the lectin complement pathway in post-streptococcal acute glomerulonephritis,” Pathology International, vol. 57, no. 6, pp. 351–357, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Ohsawa, H. Ohi, M. Endo, T. Fujita, M. Matsushita, and T. Fujita, “Evidence of lectin complement pathway activation in poststreptococcal glomerulonephritis,” Kidney International, vol. 56, no. 3, pp. 1158–1160, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Hagiwara, H. Ohi, Y. Eishi et al., “A case of renal sarcoidosis with complement activation via the lectin pathway,” American Journal of Kidney Diseases, vol. 45, no. 3, pp. 580–587, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Kusaba, I. Ohsawa, M. Ishii et al., “Evidence of immunopathological traces in mucormycosis: an autopsy case,” Clinical and Experimental Nephrology, vol. 14, no. 4, pp. 396–400, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Ohsawa, H. Ohi, M. Tamano et al., “Cryoprecipitate of patients with cryoglobulinemic glomerulonephritis contains molecules of the lectin complement pathway,” Clinical Immunology, vol. 101, no. 1, pp. 59–66, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. L. A. Van Es, “Pathogenesis of IgA nephropathy,” Kidney International, vol. 41, no. 6, pp. 1720–1729, 1992. View at Google Scholar · View at Scopus
  35. S. Suzuki, Y. Nakatomi, H. Sato, H. Tsukada, and M. Arakawa, “Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA neuropathy,” Lancet, vol. 343, no. 8888, pp. 12–16, 1994. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Gong, Z. Liu, and L. Li, “Mannose-binding lectin gene polymorphism associated with the patterns of glomerular immune deposition in IgA nephropathy,” Scandinavian Journal of Urology and Nephrology, vol. 35, no. 3, pp. 228–232, 2001. View at Publisher · View at Google Scholar · View at Scopus